Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases

INTRODUCTION: This study aimed to determine whether the introduction of anti-SARS-CoV-2 vaccines and the dominance of the omicron variant had a significant impact on the outcome of COVID-19 in patients with systemic autoimmune rheumatic diseases (SAIRDs). METHODS: Using data entered to the Greek Rhe...

Descripción completa

Detalles Bibliográficos
Autores principales: Papagoras, Charalampos, Zioga, Nikoleta, Papadopoulos, Vasileios, Gerolymatou, Nafsika, Kalavri, Eleni, Bounos, Christos, Simopoulou, Theodora, Fragoulis, George E., Panopoulos, Stylianos, Fragiadaki, Kalliopi, Evangelatos, Gerasimos, Bournia, Vasiliki-Kalliopi, Arida, Aikaterini, Karamanakos, Anastasios, Pappa, Maria, Kravvariti, Evrydiki, Deftereou, Kleopatra, Kougkas, Nikolaos, Zampeli, Evangelia, Kataxaki, Evangelia, Melissaropoulos, Konstantinos, Barouta, Georgia, Panagiotopoulos, Alexandros, Koutsianas, Christos, Liossis, Stamatis-Nick, Georgiou, Panagiotis, Dimitroulas, Theodoros, Tektonidou, Maria G., Bogdanos, Dimitrios P., Elezoglou, Antonia, Voulgari, Paraskevi V., Sfikakis, Petros P., Vassilopoulos, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640401/
https://www.ncbi.nlm.nih.gov/pubmed/37731083
http://dx.doi.org/10.1007/s10067-023-06769-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640401/
https://www.ncbi.nlm.nih.gov/pubmed/37731083
http://dx.doi.org/10.1007/s10067-023-06769-4

Ejemplares similares